Table 3. Surgical pathologic diagnosis of the study patients.
| Variable | N=416 (%) |
|---|---|
| Non-malignant | 207 (49.8) |
| Nodular hyperplasia | 47 (11.3) |
| Follicular adenoma | 103 (24.8) |
| Hürthle cell adenoma | 57 (13.7) |
| NIFTP | 63 (15.1) |
| Malignant | 146 (35.1) |
| cPTC | 23 (5.5) |
| fvPTC | 55 (13.3) |
| FTC | 59 (14.2) |
| HCC | 5 (1.2) |
| Poorly DTC | 3 (0.7) |
| MTC | 1 (0.2) |
NIFTP, noninvasive follicular thyroid neoplasm with papillary-like nuclear features; cPTC, conventional papillary thyroid carcinoma; fvPTC, follicular variant papillary thyroid carcinoma; FTC, follicular thyroid carcinoma; HCC, Hurthle cell carcinoma; DTC, differentiated thyroid carcinoma; MTC, medullary thyroid carcinoma.